MoneyWorks4Me

Natural Capsules - Quaterly Results

08 Feb 2022 Evaluate
A decent increase of about 72.92% in the turnover to Rs. 376.10 millions was observed for the quarter ended December 2021. The turnover stood at Rs. 217.50 millions during the similar quarter previous year.Net Profit witnessed a 154.94% growth almost the double from Rs. 16.20 millions to Rs. 41.30  millions  of same quarter last year.Operating profit for the quarter ended December 2021 rose to 77.60 millions as compared to 33.80 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 376.10 217.50 72.92 935.20 564.10 65.79 795.10 615.50 29.18
Other Income 0.60 0.10 500.00 2.00 5.20 -61.54 7.30 9.60 -23.96
PBIDT 77.60 33.80 129.59 175.00 79.50 120.13 116.90 62.60 86.74
Interest 5.70 0.30 1800.00 12.90 2.20 486.36 3.70 7.70 -51.95
PBDT 71.90 33.50 114.63 162.10 99.10 63.57 135.00 54.90 145.90
Depreciation 12.50 10.90 14.68 36.40 31.70 14.83 43.10 41.20 4.61
PBT 59.40 22.60 162.83 125.70 67.40 86.50 91.90 13.70 570.80
TAX 18.10 6.40 182.81 37.10 14.50 155.86 22.40 5.10 339.22
Deferred Tax 1.60 0.90 77.78 4.60 -2.30 -300.00 0.20 -1.40 -114.29
PAT 41.30 16.20 154.94 88.60 52.90 67.49 69.50 8.60 708.14
Equity 70.10 62.30 12.52 70.10 62.30 12.52 62.30 62.30 0.00
PBIDTM(%) 20.63 15.54 32.77 18.71 14.09 32.78 14.70 10.17 44.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..